Disseminated zygomycosis in a neutropenic patient: Successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 192-196

  Gonzalez, Corina E ^a   Couriel, Daniel R ^a   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCORMYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031051138     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.192     Document Type: Article

References (7)

1. Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis 1989; 11: 741-54.
2. Cho SY, Choi HY. Opportunistic fungal infection among cancer patients. A ten-year autopsy study. Am J Clin Pathol 1979;72:617-21.
3. Walsh TJ, Hiemenz J, Pizzo PA. Editorial response: evolving risk factors for invasive fungal infections - all neutropenic patients are not the same. Clin Infect Dis 1994; 18:793-8.
4. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(suppl 1):S126-9.
5. Lehrer RI, Howard DH, Sypherd PS, et al. Mucormycosis. Ann Intern Med 1980;93:93-108.
6. Hutter RVP. Phycomycetous infection (mucormycosis) in cancer patients: a complication of therapy. Cancer 1959; 12:330-50.
7. Baker RD. Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses. Mucormycosis, aspergillosis, and cryptococcosis. Am J Clin Pathol 1962;37:358-73.